TGFB1 and silicosis: Ongoing research into treatments for silicosis includes anti-fibrotic agents, anti-cytokine therapies, agents targeting autophagy-lysosome systems, antioxidants, agents that increase cyclic adenosine monophosphate (cAMP), and those that affect TGF-β.